4 BlackRock Jade Biosciences Trades
BlackRock acquired 2.31M Jade Biosciences shares worth $41M. That's 0.00% of their equity portfolio (2522nd largest holding). The investor owns 5.98% of the outstanding Jade Biosciences stock. BlackRock started to build up the position in Jade Biosciences in Q2 2025 and continued to invest until Q4 2025. Since then they sold 556k shares.
News about Jade Biosciences, Inc. and BlackRock
Aerovate Thertapeutics to explore strategic alternatives
Aerovate Therapeutics (AVTE) announces a review of strategic alternatives, including potential acquisition, merger, or liquidation.
Aerovate Therapeutics to Explore Strategic Alternatives
WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), which previously announced it was halting enrollment and shutti...
The 3 Hottest Stock Downgrades From Last Week
Wall Street’s leading analysts have been adjusting their S&P 500 forecasts in recent days. Driven by potential Federal Reserve interest rate cuts, strong per...
The 3 Hottest Stock Downgrades From Last Week
Wall Street's leading analysts have been adjusting their S&P 500 forecasts in recent days. Driven by potential Federal Reserve interest rate cuts, strong per...